pharma · Asthma · Multiple Sclerosis · TEVA
Teva Pharma
Teva Pharma GmbH
Teva Biotech is a pharma organization headquartered in TEL AVIV, DE. It trades on NYSE under ticker TEVA. Primary therapeutic focus areas include Asthma, Multiple Sclerosis, Pain, Crohn's Disease, Seasonal Allergic Rhini
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV HQ
126 Employees
Public company Type
TEVA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
- Employees
- 126
- Programs
- 473
- Drugs
- 447
- Patents
- 454
Obatoclax Mesylate, Carboplatine and Etoposide
Phase 3 · small molecule · Extensive-stage Small Cell Lung Cancer
Obatoclax Mesylate, Carboplatine and Etoposide for Extensive-stage Small Cell Lung Cancer is a Phase 3 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Internal code C41601/3099
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Teva Pharma GmbH
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Extensive-stage Small Cell Lung Cancer
- Status
- terminated
- Trials
- 1